KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Beginning Cash Balance: 2010-2025

Historic Beginning Cash Balance for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $267.3 million.

  • Emergent BioSolutions' Beginning Cash Balance rose 314.42% to $267.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.7 million, marking a year-over-year increase of 87.82%. This contributed to the annual value of $105.6 million for FY2024, which is 83.57% down from last year.
  • Emergent BioSolutions' Beginning Cash Balance amounted to $267.3 million in Q3 2025, which was up 79.28% from $149.1 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Beginning Cash Balance high stood at $640.0 million for Q1 2023, and its period low was $64.5 million during Q3 2024.
  • Moreover, its 3-year median value for Beginning Cash Balance was $111.2 million (2024), whereas its average is $197.4 million.
  • Its Beginning Cash Balance has fluctuated over the past 5 years, first plummeted by 82.62% in 2024, then soared by 314.42% in 2025.
  • Over the past 5 years, Emergent BioSolutions' Beginning Cash Balance (Quarterly) stood at $403.8 million in 2021, then crashed by 40.32% to $241.0 million in 2022, then slumped by 63.57% to $87.8 million in 2023, then soared by 71.18% to $150.3 million in 2024, then spiked by 314.42% to $267.3 million in 2025.
  • Its Beginning Cash Balance was $267.3 million in Q3 2025, compared to $149.1 million in Q2 2025 and $101.9 million in Q1 2025.